Skip to main content
Premium Trial:

Request an Annual Quote

QuantuMDx, Scienion Partner to Commercialize Nanowire Biosensor

NEW YORK (GenomeWeb) – QuantuMDx and German microarray firm Scienion today announced that they have partnered to commercialize QuantuMDx's multiplexed nanowire array technology.

The nanowire technology is a component of QuantuMDx's Q-Poc handheld molecular diagnostic device. Molecular probes are printed on each nanowire in the array, raising multiplex potential.

The firms said in a statement that QuantuMDx has purchased Scienion's sciFlexarrayer SX, and that they will use this ultra-low-volume liquid handling technology to transfer biological material onto QuantuMDx's biosensor.

The firms also said they will launch several development projects as they push to begin mass manufacturing the nanowire biosensor.

In March Scienion's microarray manufacturing process received ISO 13485 certification